Switch to:
PowerShares Dynamic Biotech &Genome  (ARCA:PBE) Net Income: $0.00 Mil (TTM As of . 20)

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. PowerShares Dynamic Biotech &Genome's net income for the six months ended in . 20 was $0.00 Mil. Its net income for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. PowerShares Dynamic Biotech &Genome's Earnings per Share (Diluted) for the six months ended in . 20 was $.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

PowerShares Dynamic Biotech &Genome Annual Data

Net Income

PowerShares Dynamic Biotech &Genome Semi-Annual Data

Net Income

Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non-Recurring Items (NRI) - Tax Expense + Others
= - Depreciation, Depletion and Amortization - Interest Expense - Non-Recurring Items (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non-Recurring Items (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

PowerShares Dynamic Biotech &Genome's Net Income for the fiscal year that ended in . 20 is calculated as

PowerShares Dynamic Biotech &Genome's Net Income for the quarter that ended in . 20 is calculated as


For stock reported semi-annually, GuruFocus uses latest annual data as the TTM data. Net Income for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

Net income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

PowerShares Dynamic Biotech &Genome's Earnings per Share (Diluted) (EPS) for the quarter that ended in . 20 is calculated as

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Related Terms


Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK